heart pain ten days after first pfizer vaccine administration; diffuse chest pain; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the ra-web. regulatory number: it-minisal02-843245. a 26 year-old female patient received bnt162b2 (comirnaty), intramuscular, administered in arm left, administration date 29dec2021 (lot number: fk6304) as dose 1, single and administration date 05feb2022 (batch/lot number: unknown) as dose 2, single for covid-19 immunisation. relevant medical history included: "interventricular defect from birth" (unspecified if ongoing). concomitant medication(s) included: nuvaring taken for contraception. the following information was reported: angina pectoris (medically significant) with onset 08jan2022, outcome "recovering", described as "heart pain ten days after first pfizer vaccine administration"; chest pain (non-serious) with onset 08jan2022, outcome "recovering", described as "diffuse chest pain". the patient underwent the following laboratory tests and procedures: cardiovascular examination: unknown results; echocardiogram: unknown results, notes: within 72 h. reported administration of 2nd dose of vaccine on 05feb2022 that did not change the symptoms previously experienced. impact on quality of life (7/10). reporter comment: interventricular defect from birth. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected.; reporter's comments: interventricular defect from birth

test name: cardiac examination; result unstructured data: test result:unknown results; test name: echocardiogram; result unstructured data: test result:unknown results; comments: within 72 h

na

na